Triamcinolone Acetonide Injectable Suspension - 40mg

Triamcinolone Acetonide Injectable Suspension - 40mg

Triamcinolone Acetonide Injectable Suspension 40 mg/mL is a corticosteroid injectable formulated for intramuscular administration. Supplied in a convenient 1 mL vial with 25 vials per carton, it is commonly used in ophthalmic and medical settings for the treatment of intermediate and posterior uveitis and capillary hemangiomas when clinically indicated. 
  • Contains Triamcinolone Acetonide 40 mg/mL, a potent corticosteroid.
  • Sterile injectable suspension supplied in 1 mL vials.
  • Packaged 25 vials per carton (CT/25) for clinical inventory management.
  • Formulated with Benzyl Alcohol as a preservative for product stability.
  • Intended for intramuscular administration only.
  • Store at room temperature.
  • Designed for professional use in ophthalmic and medical practices.


Brand: Amneal Pharmaceuticals
SEE PROFESSIONAL PRICING: REQUEST ACCESS

PO-6621  Out of stock until (approx): 10/16/2026

This product is DSCSA tracked.

Related Products

Interested in Professional Pricing?

Get access to wholesale pricing in three easy steps.

1

Tell Us About Your Business

Complete our short account application.

2

We Verify Your Account

Our team confirms your eye care business.

3

Access Professional Pricing

Shop wholesale pricing on more than 3,000 SKUs.

Request Access

Already an Amcon Customer?

Let's get you taken care of.

Do you have access to order on our Web Store/JAOS?

  • If you have access to the Amcon Web Store, visit our web store, click the link in the top right to sign in, and purchase these products today.
  • If you have access, sign in to JAOS here. If these products are not on your order form, contact your sales representative.

Don't have web access but have a customer number with Amcon Labs?

  • Contact our sales team today, and we will take care of you as soon as possible!

Interested in learning more?

Stay up to date with the latest from Amcon Labs by joining our free newsletter:

. .